Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2

In less than eight months, the COVID-19 (coronavirus disease 2019) caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus has resulted in over 20,000,000 confirmed cases and over 700,000 deaths around the world. With the increasing worldwide spreading of this disease, the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qizhang, Wang, Zhiying, Zheng, Qiang, Liu, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448953/
https://www.ncbi.nlm.nih.gov/pubmed/32868983
http://dx.doi.org/10.1016/j.csbj.2020.08.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448953/
https://www.ncbi.nlm.nih.gov/pubmed/32868983
http://dx.doi.org/10.1016/j.csbj.2020.08.016

Ejemplares similares